430 related articles for article (PubMed ID: 17462458)
41. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma.
Sakata J; Shirai Y; Wakai T; Kaneko K; Hatakeyama K
Eur J Surg Oncol; 2008 Apr; 34(4):433-8. PubMed ID: 17475439
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution.
Brachet D; Lermite E; Rouquette A; Lorimier G; Hamy A; Arnaud JP
Dis Colon Rectum; 2009 Mar; 52(3):475-83. PubMed ID: 19333049
[TBL] [Abstract][Full Text] [Related]
43. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
[TBL] [Abstract][Full Text] [Related]
44. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.
Cillo U; Vitale A; Brolese A; Zanus G; Neri D; Valmasoni M; Bonsignore P; Grigoletto F; Burra P; Farinati F; D'Amico DF
J Surg Oncol; 2007 Mar; 95(3):213-20. PubMed ID: 17066432
[TBL] [Abstract][Full Text] [Related]
45. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
47. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.
Yamamoto J; Kosuge T; Saiura A; Sakamoto Y; Shimada K; Sano T; Takayama T; Sugawara Y; Yamaguchi T; Kokudo N; Makuuchi M
Jpn J Clin Oncol; 2007 Apr; 37(4):287-95. PubMed ID: 17553819
[TBL] [Abstract][Full Text] [Related]
49. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy.
Lu MD; Yin XY; Xie XY; Xu HX; Xu ZF; Liu GJ; Kuang M; Zheng YL
Br J Surg; 2005 Nov; 92(11):1393-8. PubMed ID: 16044409
[TBL] [Abstract][Full Text] [Related]
50. Repeated liver resection for recurrent hepatocellular carcinoma.
Faber W; Seehofer D; Neuhaus P; Stockmann M; Denecke T; Kalmuk S; Warnick P; Bahra M
J Gastroenterol Hepatol; 2011 Jul; 26(7):1189-94. PubMed ID: 21410751
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter.
Hu RH; Lee PH; Chang YC; Yu SC; Ho MC; Wu YM
Hepatogastroenterology; 2003; 50(54):2043-8. PubMed ID: 14696462
[TBL] [Abstract][Full Text] [Related]
52. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
[TBL] [Abstract][Full Text] [Related]
54. Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.
Ariizumi S; Katagiri S; Katsuragawa H; Kotera Y; Yamamoto M
Dig Surg; 2007; 24(5):342-8. PubMed ID: 17785977
[TBL] [Abstract][Full Text] [Related]
55. Repeat hepatectomy for recurrent colorectal metastases.
Sugawara G; Isogai M; Kaneoka Y; Suzuki M; Yamaguchi A
Surg Today; 2005; 35(4):282-9. PubMed ID: 15815843
[TBL] [Abstract][Full Text] [Related]
56. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
57. Outcome of patients with fibrolamellar hepatocellular carcinoma.
Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
[TBL] [Abstract][Full Text] [Related]
58. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.
Kornberg A; Küpper B; Tannapfel A; Katenkamp K; Thrum K; Habrecht O; Wilberg J
Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941
[TBL] [Abstract][Full Text] [Related]
59. Surgical treatment of recurrent hepatocellular carcinoma.
Zhou XD; Yu YQ; Tang ZY; Yang BH; Lu JZ; Lin ZY; Ma ZC; Xu DB; Zhang BH; Zheng YX
Hepatogastroenterology; 1993 Aug; 40(4):333-6. PubMed ID: 8406302
[TBL] [Abstract][Full Text] [Related]
60. Recurrence after resection of hepatocellular carcinoma.
Shen BY; Li HW; Regimbeau JM; Belghiti J
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):401-5. PubMed ID: 14607715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
